These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9616968)

  • 1. Clinical and pathological prognostic factors in canine mammary tumors.
    Pérez Alenza MD; Peña L; Nieto AI; Castaño M
    Ann Ist Super Sanita; 1997; 33(4):581-5. PubMed ID: 9616968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of histological grading in noninflammatory canine mammary carcinomas in a prospective study with two-year follow-up: relationship with clinical and histological characteristics.
    Peña L; De Andrés PJ; Clemente M; Cuesta P; Pérez-Alenza MD
    Vet Pathol; 2013 Jan; 50(1):94-105. PubMed ID: 22688585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative treatment outcome in canine mammary tumors. Multivariate analysis of the prognostic value of pre- and postoperatively available information.
    Betz D; Schoenrock D; Mischke R; Baumgärtner W; Nolte I
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):235-42. PubMed ID: 22911254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.
    Sorenmo KU; Rasotto R; Zappulli V; Goldschmidt MH
    Vet Pathol; 2011 Jan; 48(1):85-97. PubMed ID: 21147765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of E-cadherin, P-cadherin and beta-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival.
    Gama A; Paredes J; Gärtner F; Alves A; Schmitt F
    Vet J; 2008 Jul; 177(1):45-53. PubMed ID: 17631398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours.
    Santos A; Lopes C; Marques RM; Amorim I; Ribeiro J; Frias C; Vicente C; Gärtner F; de Matos A
    Vet J; 2011 Jul; 189(1):43-8. PubMed ID: 20598596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of regional lymph node status in canine mammary carcinomas.
    Szczubiał M; Łopuszynski W
    Vet Comp Oncol; 2011 Dec; 9(4):296-303. PubMed ID: 22077411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
    Queiroga FL; Pires I; Lobo L; Lopes CS
    Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIB-1 labelling indices according to clinico-pathological variables in canine mammary tumours: a multivariate study.
    De Matos AJ; Lopes CC; Faustino AM; Carvalheira JG; Dos Santos MS; Rutteman GR; Gärtner Mde F
    Anticancer Res; 2006; 26(3A):1821-6. PubMed ID: 16827113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cox-2 levels in canine mammary tumors, including inflammatory mammary carcinoma: clinicopathological features and prognostic significance.
    Queiroga FL; Perez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
    Anticancer Res; 2005; 25(6B):4269-75. PubMed ID: 16309227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic status of p53 gene mutation in canine mammary carcinoma.
    Wakui S; Muto T; Yokoo K; Yokoo R; Takahashi H; Masaoka T; Hano H; Furusato M
    Anticancer Res; 2001; 21(1B):611-6. PubMed ID: 11299814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective analysis of immunohistochemically determined estrogen receptor alpha and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog.
    de Las Mulas JM; Millán Y; Dios R
    Vet Pathol; 2005 Mar; 42(2):200-12. PubMed ID: 15753474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
    Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
    Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced PTEN protein expression and its prognostic implications in canine and feline mammary tumors.
    Ressel L; Millanta F; Caleri E; Innocenti VM; Poli A
    Vet Pathol; 2009 Sep; 46(5):860-8. PubMed ID: 19429983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining of metallothionein in canine mammary tumors: better survival with higher expression.
    Cardoso SV; Caliari MV; de Aguiar MC; Cassali GD
    Oncol Rep; 2004 Dec; 12(6):1317-21. PubMed ID: 15547757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008).
    Marconato L; Romanelli G; Stefanello D; Giacoboni C; Bonfanti U; Bettini G; Finotello R; Verganti S; Valenti P; Ciaramella L; Zini E
    J Am Vet Med Assoc; 2009 Oct; 235(8):967-72. PubMed ID: 19827983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in canine mammary tumors: a multivariate study of 202 consecutive cases.
    Hellmén E; Bergström R; Holmberg L; Spångberg IB; Hansson K; Lindgren A
    Vet Pathol; 1993 Jan; 30(1):20-7. PubMed ID: 8442324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
    Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
    Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.